Skip to content

Clinical trials

Terminated Phase 1/2 Thrombocytopenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Phase: Phase 1/2 Status: Terminated Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20121
20152
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Protalex, Inc.2
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Meghan McCormick1
PrECOG, LLC.1
University of Ulm1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia6
Purpura, Thrombocytopenic, Idiopathic2
Amenorrhea1
Anemia, Aplastic1
Hemostatic Disorders1
Leukemia1
Leukemia, Lymphocytic, Chronic, B-Cell1
Leukemia, Myeloid, Acute1
Menorrhagia1
Neoplasms1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.